🇺🇸 FDA
Patent

US 9872865

Compositions for improving cell viability and methods of use thereof

granted A61KA61K31/192A61K31/575

Quick answer

US patent 9872865 (Compositions for improving cell viability and methods of use thereof) held by Amylyx Pharmaceuticals, Inc. expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amylyx Pharmaceuticals, Inc.
Grant date
Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/192, A61K31/575, A61P, A61P25/28